Bristol Myers Squibb (BMY) Gross Profit Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.44% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
15.45% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-0.16% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
13.38% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
7.57% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-65.16% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1.22% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-1.22% |
| Dec 31, 2025 |
11.62% |
| Sep 30, 2025 |
-1.66% |
| Jun 30, 2025 |
-0.41% |
| Mar 31, 2025 |
-8.56% |
| Dec 31, 2024 |
-13.77% |
| Sep 30, 2024 |
5.61% |
| Jun 30, 2024 |
6.99% |
| Mar 31, 2024 |
1.85% |
| Dec 31, 2023 |
-0.92% |
| Sep 30, 2023 |
-4.57% |
| Jun 30, 2023 |
-8.91% |
| Mar 31, 2023 |
-4.42% |
| Dec 31, 2022 |
-8.47% |
| Sep 30, 2022 |
-5.01% |
| Jun 30, 2022 |
-0.91% |
| Mar 31, 2022 |
11.48% |
| Dec 31, 2021 |
18.03% |
| Sep 30, 2021 |
16.11% |
| Jun 30, 2021 |
24.51% |
| Mar 31, 2021 |
15.63% |
| Dec 31, 2020 |
49.61% |
| Sep 30, 2020 |
90.61% |
| Jun 30, 2020 |
72.75% |
| Mar 31, 2020 |
73.80% |
| Dec 31, 2019 |
24.98% |
| Sep 30, 2019 |
4.30% |
| Jun 30, 2019 |
5.44% |
| Mar 31, 2019 |
13.49% |
| Dec 31, 2018 |
13.38% |
| Sep 30, 2018 |
10.01% |
| Jun 30, 2018 |
14.10% |
| Mar 31, 2018 |
-1.50% |
| Dec 31, 2017 |
0.29% |
| Sep 30, 2017 |
1.60% |
| Jun 30, 2017 |
-2.46% |
| Mar 31, 2017 |
9.73% |
| Dec 31, 2016 |
15.05% |
| Sep 30, 2016 |
21.70% |
| Jun 30, 2016 |
16.35% |
| Mar 31, 2016 |
4.54% |
| Dec 31, 2015 |
1.31% |
| Sep 30, 2015 |
1.99% |
| Jun 30, 2015 |
8.70% |
| Mar 31, 2015 |
12.35% |
| Dec 31, 2014 |
3.91% |
| Sep 30, 2014 |
0.83% |
| Jun 30, 2014 |
-1.43% |
| Mar 31, 2014 |
2.71% |
| Dec 31, 2013 |
1.67% |
| Sep 30, 2013 |
5.13% |
| Jun 30, 2013 |
-8.07% |
| Mar 31, 2013 |
-29.89% |
| Dec 31, 2012 |
-23.76% |
| Sep 30, 2012 |
-30.19% |
| Jun 30, 2012 |
-19.10% |
| Mar 31, 2012 |
7.63% |
| Dec 31, 2011 |
10.55% |
| Sep 30, 2011 |
11.94% |
| Jun 30, 2011 |
13.23% |
| Mar 31, 2011 |
4.77% |
| Dec 31, 2010 |
2.69% |
| Sep 30, 2010 |
1.35% |
| Jun 30, 2010 |
1.48% |
| Mar 31, 2010 |
10.90% |
